Alexander Schepart PharmD, MBA , Arianna Burton PharmD , Larry Durkin MBA , Allison Fuller BA , Ellyn Charap MSc , Rahul Bhambri PharmD, MBA , Faraz S. Ahmad MD, MS
{"title":"Artificial intelligence–enabled tools in cardiovascular medicine: A survey of current use, perceptions, and challenges","authors":"Alexander Schepart PharmD, MBA , Arianna Burton PharmD , Larry Durkin MBA , Allison Fuller BA , Ellyn Charap MSc , Rahul Bhambri PharmD, MBA , Faraz S. Ahmad MD, MS","doi":"10.1016/j.cvdhj.2023.04.003","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Numerous artificial intelligence (AI)-enabled tools for cardiovascular diseases have been published, with a high impact on public health. However, few have been adopted into, or have meaningfully affected, routine clinical care.</p></div><div><h3>Objective</h3><p>To evaluate current awareness, perceptions, and clinical use of AI-enabled digital health tools for patients with cardiovascular disease, and challenges to adoption.</p></div><div><h3>Methods</h3><p>This mixed-methods study included interviews with 12 cardiologists and 8 health information technology (IT) administrators, and a follow-on survey of 90 cardiologists and 30 IT administrators.</p></div><div><h3>Results</h3><p>We identified 5 major challenges: (1) limited knowledge, (2) insufficient usability, (3) cost constraints, (4) poor electronic health record interoperability, and (5) lack of trust. A minority of cardiologists were using AI tools; more were prepared to implement AI tools, but their sophistication level varied greatly.</p></div><div><h3>Conclusion</h3><p>Most respondents believe in the potential of AI-enabled tools to improve care quality and efficiency, but they identified several fundamental barriers to wide-scale adoption.</p></div>","PeriodicalId":72527,"journal":{"name":"Cardiovascular digital health journal","volume":"4 3","pages":"Pages 101-110"},"PeriodicalIF":2.6000,"publicationDate":"2023-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282011/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular digital health journal","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666693623000282","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 1
Abstract
Background
Numerous artificial intelligence (AI)-enabled tools for cardiovascular diseases have been published, with a high impact on public health. However, few have been adopted into, or have meaningfully affected, routine clinical care.
Objective
To evaluate current awareness, perceptions, and clinical use of AI-enabled digital health tools for patients with cardiovascular disease, and challenges to adoption.
Methods
This mixed-methods study included interviews with 12 cardiologists and 8 health information technology (IT) administrators, and a follow-on survey of 90 cardiologists and 30 IT administrators.
Results
We identified 5 major challenges: (1) limited knowledge, (2) insufficient usability, (3) cost constraints, (4) poor electronic health record interoperability, and (5) lack of trust. A minority of cardiologists were using AI tools; more were prepared to implement AI tools, but their sophistication level varied greatly.
Conclusion
Most respondents believe in the potential of AI-enabled tools to improve care quality and efficiency, but they identified several fundamental barriers to wide-scale adoption.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
